Displaying 109 - 120 of 174
Viral Hepatitis

Benefits of HBIG+NA prophylactic therapy post-LT

Webcasts
View
Viral Hepatitis

Is NA monotherapy sufficient for prevention of HBV recurrence post-LT?

Webcasts
View
Viral Hepatitis

Debate/ Q&A

Webcasts
View
Viral Hepatitis
Gilead: Q the Experts on HDV

Gilead: Q the Experts on HDV

Webcasts
View
Viral Hepatitis

GlaxoSmithKline: Nothing about me without me

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Should we focus on managing QoL?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Debate the issues

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Event summary

Webcasts
View
Immune-Mediated and Cholestatic Diseases

How do we holistically treat patients with PBC?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Should we focus on monitoring ALP?

Webcasts
View
Viral Hepatitis

Bringing hepatitis delta out of the shadows

Webcasts
View
Viral Hepatitis

What can be achieved today in hepatitis delta?

Webcasts
View
Displaying 109 - 120 of 174